Periscope Capital’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Periscope Capital’s Portfolio DMAAR Stock Details DMAAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.44K	Hold	75,000	–	–	﹤0.01%	485
2026 Q2	$8.25K	Hold	75,000	–	–	﹤0.01%	460
2026 Q1	$4.5K	Hold	75,000	–	–	﹤0.01%	414
2025 Q4	$14K	Hold	75,000	–	–	﹤0.01%	324
2025 Q3	$16.3K	Buy	+75,000	New	+$13.9K	﹤0.01%	261

Other funds holding DMAAR

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Periscope Capital's DMAAR Position: Q3 2026 in Review

Periscope Capital held its Drugs Made In America Acquisition Corp Rights (DMAAR) position steady in Q3 2026 at 75,000 shares worth $8.44K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Periscope Capital first reported a position in DMAAR in Q3 2025 and has held it in 5 quarters since. The position peaked at $16.3K in Q3 2025. 5 funds tracked by Wall St. Rank hold DMAAR as of Q3 2026.

Periscope Capital held 75,000 shares of Drugs Made In America Acquisition Corp Rights worth $8.44K as of Q3 2026.
Periscope Capital left its Drugs Made In America Acquisition Corp Rights share count unchanged in Q3 2026.
Drugs Made In America Acquisition Corp Rights made up ﹤0.01% of Periscope Capital's portfolio in Q3 2026, its #485 holding.
Periscope Capital first reported a position in Drugs Made In America Acquisition Corp Rights in Q3 2025 and has held it in 5 quarters since.
Periscope Capital's Drugs Made In America Acquisition Corp Rights position peaked at $16.3K in Q3 2025.
5 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q3 2026.

Based on Periscope Capital's 13F filing for Q3 2026, filed 6 Nov 2026.